{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Formamides : Questions médicales les plus fréquentes",
"headline": "Formamides : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Formamides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-21",
"dateModified": "2025-04-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Formamides"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Formiates",
"url": "https://questionsmedicales.fr/mesh/D005561",
"about": {
"@type": "MedicalCondition",
"name": "Formiates",
"code": {
"@type": "MedicalCode",
"code": "D005561",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.241.081.420"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "N,N-Diméthyl-formamide",
"alternateName": "Dimethylformamide",
"url": "https://questionsmedicales.fr/mesh/D004126",
"about": {
"@type": "MedicalCondition",
"name": "N,N-Diméthyl-formamide",
"code": {
"@type": "MedicalCode",
"code": "D004126",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.241.081.420.500.387"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Formamides",
"alternateName": "Formamides",
"code": {
"@type": "MedicalCode",
"code": "D005559",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Gang Feng",
"url": "https://questionsmedicales.fr/author/Gang%20Feng",
"affiliation": {
"@type": "Organization",
"name": "School of Chemistry and Chemical Engineering, Chongqing University, Daxuecheng South Rd. 55, 401331 Chongqing, China."
}
},
{
"@type": "Person",
"name": "Martin Ferus",
"url": "https://questionsmedicales.fr/author/Martin%20Ferus",
"affiliation": {
"@type": "Organization",
"name": "J. Heyrovský Institute of Physical Chemistry, Czech Academy of Sciences, Dolejškova 3, CZ 18223 Prague 8, Czech Republic."
}
},
{
"@type": "Person",
"name": "Raffaele Saladino",
"url": "https://questionsmedicales.fr/author/Raffaele%20Saladino",
"affiliation": {
"@type": "Organization",
"name": "Department of Ecological and Biological Sciences, Via San Camillo De Lellis, Università della Tuscia, Viterbo 01100, Italy."
}
},
{
"@type": "Person",
"name": "Ernesto Di Mauro",
"url": "https://questionsmedicales.fr/author/Ernesto%20Di%20Mauro",
"affiliation": {
"@type": "Organization",
"name": "Department of Ecological and Biological Sciences, Via San Camillo De Lellis, Università della Tuscia, Viterbo 01100, Italy. Electronic address: dimauroernesto8@gmail.com."
}
},
{
"@type": "Person",
"name": "Yifu Yu",
"url": "https://questionsmedicales.fr/author/Yifu%20Yu",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Institute of Molecular Plus, Tianjin University, Tianjin, 300072, China. yyu@tju.edu.cn."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Development of data-driven modeling method for nonlinear coupling components.",
"datePublished": "2024-06-27",
"url": "https://questionsmedicales.fr/article/38937632",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-65680-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Prospector Heads: Generalized Feature Attribution for Large Models & Data.",
"datePublished": "2024-06-20",
"url": "https://questionsmedicales.fr/article/38947933",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "An Update on the iglu Software for Interpreting Continuous Glucose Monitoring Data.",
"datePublished": "2024-06-17",
"url": "https://questionsmedicales.fr/article/38885321",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1089/dia.2024.0154"
}
},
{
"@type": "ScholarlyArticle",
"name": "Communicating prostate cancer outcomes data to consumers A brief communication.",
"datePublished": "2024-06-13",
"url": "https://questionsmedicales.fr/article/38876931",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.urolonc.2024.05.022"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cross study analyses of SEND data: toxicity profile classification.",
"datePublished": "2024-06-08",
"url": "https://questionsmedicales.fr/article/38851876",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1093/toxsci/kfae072"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides carboxyliques",
"item": "https://questionsmedicales.fr/mesh/D002264"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides acycliques",
"item": "https://questionsmedicales.fr/mesh/D000144"
},
{
"@type": "ListItem",
"position": 5,
"name": "Formiates",
"item": "https://questionsmedicales.fr/mesh/D005561"
},
{
"@type": "ListItem",
"position": 6,
"name": "Formamides",
"item": "https://questionsmedicales.fr/mesh/D005559"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Formamides - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Formamides",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Formamides",
"description": "Comment diagnostiquer une exposition aux formamides ?\nQuels tests sont utilisés pour détecter les formamides ?\nQuels symptômes indiquent une intoxication aux formamides ?\nLes formamides peuvent-ils être détectés par imagerie ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Data+Collection&page=998#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Formamides",
"description": "Quels sont les symptômes d'une exposition aiguë aux formamides ?\nLes formamides provoquent-ils des effets à long terme ?\nComment les formamides affectent-ils la peau ?\nY a-t-il des symptômes spécifiques chez les enfants ?\nLes symptômes varient-ils selon la voie d'exposition ?",
"url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Data+Collection&page=998#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Formamides",
"description": "Comment prévenir l'exposition aux formamides ?\nLes travailleurs doivent-ils être formés sur les formamides ?\nQuelles mesures de sécurité doivent être mises en place ?\nLes femmes enceintes doivent-elles éviter les formamides ?\nLes équipements de protection sont-ils obligatoires ?",
"url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Data+Collection&page=998#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Formamides",
"description": "Quel est le traitement principal en cas d'intoxication aux formamides ?\nDes antidotes existent-ils pour les formamides ?\nComment traiter les irritations cutanées causées par les formamides ?\nLes soins d'urgence sont-ils nécessaires pour l'exposition ?\nQuel suivi médical est recommandé après exposition ?",
"url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Data+Collection&page=998#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Formamides",
"description": "Quelles complications peuvent survenir après exposition ?\nLes formamides peuvent-ils causer des cancers ?\nComment les formamides affectent-ils le système nerveux ?\nY a-t-il des risques pour la reproduction ?\nLes effets des formamides sont-ils réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Data+Collection&page=998#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Formamides",
"description": "Qui est le plus à risque d'exposition aux formamides ?\nLes enfants sont-ils plus vulnérables aux formamides ?\nQuels environnements augmentent le risque d'exposition ?\nLes personnes âgées sont-elles à risque ?\nLes allergies augmentent-elles le risque d'effets ?",
"url": "https://questionsmedicales.fr/mesh/D005559?mesh_terms=Data+Collection&page=998#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une exposition aux formamides ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les formamides ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter les formamides."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication aux formamides ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vertiges et des irritations cutanées."
}
},
{
"@type": "Question",
"name": "Les formamides peuvent-ils être détectés par imagerie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'imagerie ne détecte pas les formamides, mais peut montrer des effets sur les organes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à établir un lien entre les symptômes et l'exposition aux formamides."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une exposition aiguë aux formamides ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes aigus incluent des maux de tête, des nausées et des irritations respiratoires."
}
},
{
"@type": "Question",
"name": "Les formamides provoquent-ils des effets à long terme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une exposition prolongée peut entraîner des problèmes neurologiques et rénaux."
}
},
{
"@type": "Question",
"name": "Comment les formamides affectent-ils la peau ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des irritations cutanées, des rougeurs et des démangeaisons."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les enfants ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes similaires, mais sont plus sensibles aux effets."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon la voie d'exposition ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'inhalation, l'ingestion ou le contact cutané peuvent provoquer des symptômes différents."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux formamides ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité."
}
},
{
"@type": "Question",
"name": "Les travailleurs doivent-ils être formés sur les formamides ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle pour les travailleurs."
}
},
{
"@type": "Question",
"name": "Quelles mesures de sécurité doivent être mises en place ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Installer des systèmes de ventilation et des douches de sécurité dans les zones de travail."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles éviter les formamides ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition aux formamides peut être nocive pour le fœtus, il faut éviter tout contact."
}
},
{
"@type": "Question",
"name": "Les équipements de protection sont-ils obligatoires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le port d'équipements de protection est obligatoire dans les environnements à risque."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal en cas d'intoxication aux formamides ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement consiste à retirer la personne de l'exposition et à administrer des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les formamides ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique pour les intoxications aux formamides."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées causées par les formamides ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est recommandé de rincer la zone affectée à l'eau et d'appliquer des crèmes apaisantes."
}
},
{
"@type": "Question",
"name": "Les soins d'urgence sont-ils nécessaires pour l'exposition ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en cas d'exposition sévère, des soins d'urgence sont essentiels pour éviter des complications."
}
},
{
"@type": "Question",
"name": "Quel suivi médical est recommandé après exposition ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical est conseillé pour surveiller les effets à long terme sur la santé."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après exposition ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des troubles respiratoires, neurologiques et rénaux."
}
},
{
"@type": "Question",
"name": "Les formamides peuvent-ils causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien potentiel entre l'exposition aux formamides et certains cancers."
}
},
{
"@type": "Question",
"name": "Comment les formamides affectent-ils le système nerveux ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer des troubles neurologiques, y compris des maux de tête et des vertiges."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques pour la reproduction ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition aux formamides peut affecter la fertilité et le développement fœtal."
}
},
{
"@type": "Question",
"name": "Les effets des formamides sont-ils réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains effets peuvent être réversibles, mais d'autres peuvent causer des dommages permanents."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque d'exposition aux formamides ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs dans l'industrie chimique et ceux manipulant des produits contenant des formamides."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus vulnérables aux formamides ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants sont plus sensibles aux effets toxiques des formamides en raison de leur développement."
}
},
{
"@type": "Question",
"name": "Quels environnements augmentent le risque d'exposition ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les environnements industriels et de laboratoire présentent un risque accru d'exposition."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus sensibles aux effets toxiques des formamides."
}
},
{
"@type": "Question",
"name": "Les allergies augmentent-elles le risque d'effets ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant des allergies peuvent avoir des réactions plus sévères aux formamides."
}
}
]
}
]
}
This research introduces a methodology for data-driven regression modeling of components exhibiting nonlinear characteristics, utilizing the sparse identification of nonlinear dynamics (SINDy) method....
Feature attribution, the ability to localize regions of the input data that are relevant for classification, is an important capability for ML models in scientific and biomedical domains. Current meth...
Continuous glucose monitors (CGMs) are increasingly used to provide a detailed quantification of glycemic control and glucose variability. An open-source R package iglu has been developed to assist wi...
The functionality was expanded to include automated computation of hypo- and hyperglycemia episodes with corresponding visualizations, composite metrics of glycemic control (Glycemia Risk Index (GRI),...
The updated version of iglu has been released to the Comprehensive R Archive Network (CRAN) as version 4.0.0. The corresponding Python wrapper has been released to the Python Package Index (PyPI) as v...
An updated version of iglu provides comprehensive and accessible software for analyses of CGM data that meets the needs of researchers with varying levels of programming experience. It is freely avail...
To translate and communicate outcomes data for prostate cancer from a clinical registry data into a consumer-friendly resource....
First, we analyzed real-world data from the South Australian Prostate Cancer Clinical Outcomes Collaborative (SA-PCCOC) registry for men diagnosed from 2008 to 2018 including clinical and functional o...
The 5-year prostate cancer-specific survival rate was 97%. There is a reasonably high chance of cancer returning within 5 years (17% after surgery and 14% after radiotherapy) while 1 in 3 men on activ...
This relatively simple and easily understandable consumer-oriented outcome report serves to better inform men with prostate cancer and facilitate patient-provider communication and shared decision-mak...
A SEND toxicology data transformation, harmonization and analysis platform was created to improve the identification of unique findings related to the intended target, species, and duration of dosing ...
Probiotic fermentation studies are vital in many areas, particularly when it comes to feeding applications. This work examines probiotic fermentation in oil tea crops. The assessment of tea saponin-de...
Data-independent acquisition (DIA) has become a widely used strategy for peptide and protein quantification in mass spectrometry-based proteomics studies. The integration of ion mobility separation in...
Understanding the sequential progression of cognitive impairments in Parkinson's disease (PD) is crucial for elucidating neuropathological underpinnings, refining the assessment of PD-related cognitiv...
This cross-sectional observational study included 99 people with PD who completed a neuropsychological battery. Individuals were classified as meeting the criteria for mild cognitive impairment (PD-MC...
The EBM estimated that tests assessing executive function and visuospatial ability become abnormal early in the sequence of PD-related cognitive decline. Each higher estimated stage of cognitive decli...
Findings from this study will have important clinical implications for practitioners, on specific cognitive tests to prioritise, when conducting neuropsychological evaluations with people with PD. Res...
We explored the challenges and solutions for managing data within the Whole Health System (WHS), which operates as a Learning Health System and a patient-centered healthcare approach that combines con...
Prompt learning has demonstrated impressive efficacy in the fine-tuning of multimodal large models to a wide range of downstream tasks. Nonetheless, applying existing prompt learning methods for the d...